INVO Fertility, Inc. Income (Loss) from Equity Method Investments
INVO Fertility, Inc. (IVF) reported Income (Loss) from Equity Method Investments of -$7.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-14
- INVO Fertility, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was -$7.15K.
- INVO Fertility, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was $22.17K, a 46.85% increase year-over-year.
- INVO Fertility, Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was $23.28K, a 26.07% increase year-over-year.
- INVO Fertility, Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was $12.83K.
- INVO Fertility, Inc. income (loss) from equity method investments for fiscal 2025 was $31.29K, a 245.98% increase from fiscal 2024.
- INVO Fertility, Inc. income (loss) from equity method investments for fiscal 2024 was $9.04K.
- INVO Fertility, Inc. income (loss) from equity method investments for fiscal 2023 was -$60.27K.
- INVO Fertility, Inc. income (loss) from equity method investments for fiscal 2022 was -$200.56K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.15K 10-Q · filed 2026-08-14 | $15.01K 10-Q · filed 2026-08-14 | $38.30K derived: sum of 3 quarters · filed 2026-08-14 | $51.12K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $22.17K 10-Q · filed 2026-06-22 | $45.45K derived: sum of 2 quarters · filed 2026-06-22 | $58.28K derived: sum of 3 quarters · filed 2026-06-22 | $38.37K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $23.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $36.11K derived: sum of 2 quarters · filed 2026-06-02 | $16.20K derived: sum of 3 quarters · filed 2026-08-14 | $31.29K 10-K · filed 2026-06-02 |
| 2025-09-30 | $12.83K 10-Q · filed 2025-11-17 | -$7.08K derived: sum of 2 quarters · filed 2026-08-14 | $8.01K 10-Q · filed 2025-11-17 | $26.48K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$19.91K 10-Q · filed 2026-08-14 | -$4.82K 10-Q · filed 2026-08-14 | $13.65K derived: sum of 3 quarters · filed 2026-08-14 | -$13.72K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $15.10K 10-Q · filed 2026-06-22 | $33.56K derived: sum of 2 quarters · filed 2026-06-22 | $6.19K derived: sum of 3 quarters · filed 2026-06-22 | $24.04K derived: sum of 4 quarters · filed 2026-06-22 |
| 2024-12-31 | $18.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | -$8.90K derived: sum of 2 quarters · filed 2026-06-02 | $8.94K derived: sum of 3 quarters · filed 2026-06-02 | $9.04K 10-K · filed 2026-06-02 |
| 2024-09-30 | -$27.37K 10-Q · filed 2025-11-17 | -$9.53K derived: sum of 2 quarters · filed 2025-11-17 | -$9.42K 10-Q · filed 2025-11-17 | -$37.58K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $17.85K 10-Q · filed 2025-08-14 | $17.95K 10-Q · filed 2025-08-14 | -$10.21K derived: sum of 3 quarters · filed 2025-08-14 | -$18.37K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $104.00 10-Q · filed 2025-05-20 | -$28.06K derived: sum of 2 quarters · filed 2025-05-20 | -$36.22K derived: sum of 3 quarters · filed 2025-05-20 | -$32.43K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | -$28.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | -$36.32K derived: sum of 2 quarters · filed 2025-04-30 | -$32.53K derived: sum of 3 quarters · filed 2025-04-30 | -$60.27K 10-K · filed 2025-04-30 |
| 2023-09-30 | -$8.16K 10-Q · filed 2024-11-19 | -$4.38K derived: sum of 2 quarters · filed 2024-11-19 | -$32.11K 10-Q · filed 2024-11-19 | -$22.10K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $3.79K 10-Q/A · filed 2024-11-19 | -$23.95K 10-Q/A · filed 2024-11-19 | -$13.94K derived: sum of 3 quarters · filed 2024-11-19 | -$35.41K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-03-31 | -$27.73K 10-Q · filed 2024-05-15 | -$17.73K derived: sum of 2 quarters · filed 2024-11-19 | -$39.20K derived: sum of 3 quarters · filed 2024-11-19 | -$157.18K derived: sum of 4 quarters · filed 2024-11-19 |
| 2022-12-31 | $10.01K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | -$11.46K derived: sum of 2 quarters · filed 2024-11-19 | -$129.44K derived: sum of 3 quarters · filed 2024-11-19 | -$200.56K 10-K/A · filed 2024-11-19 |
| 2022-09-30 | -$21.47K 10-Q · filed 2023-11-13 | -$139.45K derived: sum of 2 quarters · filed 2023-11-13 | -$210.56K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$117.98K 10-Q · filed 2023-08-14 | -$189.09K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |